Diaz Allene M.

CIK 00017733144 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001773314

Recent Transactions

39 trades

Disposition from Tender
Mersana Therapeutics, Inc.$MRSN
Common Stock
2026-01-06−578→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−2,200→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−734→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,800→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−416→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−1,571→ 0 total
Disposition to Issuer
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2026-01-06−2,460→ 0 total
Sale
IONIS PHARMACEUTICALS INC$IONS
Common Stock
2025-08-22$42.53/sh−1,427→ 18,368 total
Exercise/Conversion
IONIS PHARMACEUTICALS INC$IONS
Restricted Stock Unit
2025-07-15−4,079→ 5,220 total
Exercise/Conversion
IONIS PHARMACEUTICALS INC$IONS
Common Stock
2025-07-15+4,079→ 19,795 total
Award
IONIS PHARMACEUTICALS INC$IONS
Non-Qualified Stock Option (right to buy)
2025-07-01+11,518→ 11,518 total
Award
IONIS PHARMACEUTICALS INC$IONS
Restricted Stock Unit
2025-07-01+5,220→ 9,299 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2025-06-12+61,500→ 61,500 total
Sale
IONIS PHARMACEUTICALS INC$IONS
Common Stock
2024-07-16$50.17/sh−737→ 15,716 total
Sale
IONIS PHARMACEUTICALS INC$IONS
Common Stock
2024-07-16$48.94/sh−900→ 16,453 total
Exercise/Conversion
IONIS PHARMACEUTICALS INC$IONS
Restricted Stock Unit
2024-07-15−4,677→ 4,079 total
Exercise/Conversion
IONIS PHARMACEUTICALS INC$IONS
Common Stock
2024-07-15+4,677→ 17,353 total
Award
IONIS PHARMACEUTICALS INC$IONS
Non-Qualified Stock Option (right to buy)
2024-07-01+10,111→ 10,111 total
Award
IONIS PHARMACEUTICALS INC$IONS
Restricted Stock Unit
2024-07-01+4,079→ 8,756 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2024-06-11+55,000→ 55,000 total
Sale
IONIS PHARMACEUTICALS INC$IONS
Common Stock
2023-08-01$41.05/sh−657→ 12,676 total
Exercise/Conversion
IONIS PHARMACEUTICALS INC$IONS
Restricted Stock Unit
2023-07-17−5,333→ 4,677 total
Exercise/Conversion
IONIS PHARMACEUTICALS INC$IONS
Common Stock
2023-07-17+5,333→ 13,333 total
Award
IONIS PHARMACEUTICALS INC$IONS
Non-Qualified Stock Option (right to buy)
2023-07-03+10,321→ 10,321 total
Award
IONIS PHARMACEUTICALS INC$IONS
Restricted Stock Unit
2023-07-03+4,677→ 10,010 total
Award
Mersana Therapeutics, Inc.$MRSN
Common Stock
2023-06-08+14,467→ 14,467 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2023-06-08+18,355→ 18,355 total
Exercise/Conversion
IONIS PHARMACEUTICALS INC$IONS
Restricted Stock Unit
2022-07-15−8,000→ 5,333 total
Exercise/Conversion
IONIS PHARMACEUTICALS INC$IONS
Common Stock
2022-07-15+8,000→ 8,000 total
Award
IONIS PHARMACEUTICALS INC$IONS
Non-Qualified Stock Option (right to buy)
2022-07-01+12,000→ 12,000 total
Award
IONIS PHARMACEUTICALS INC$IONS
Restricted Stock Unit
2022-07-01+5,333→ 13,333 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2022-06-09+45,000→ 45,000 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2022-01-03+10,416→ 10,416 total
Award
IONIS PHARMACEUTICALS INC$IONS
Restricted Stock Unit
2021-07-15+8,000→ 8,000 total
Award
IONIS PHARMACEUTICALS INC$IONS
Non-Qualified Stock Option (right to buy)
2021-07-01+18,000→ 18,000 total
Award
Allena Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-06-03+37,000→ 37,000 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2021-03-09+39,275→ 39,275 total
Award
Allena Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-11-17+14,000→ 14,000 total
Award
Allena Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-05-06+28,000→ 28,000 total

Companies

Recent Filings

Address

C/O MERSANA THERAPEUTICS, INC. 840 MEMORIAL DRIVE

CAMBRIDGE, MA, 02139

View on SEC.gov